{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T03:17:34Z","timestamp":1783048654074,"version":"3.54.6"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Subst Abuse Treat Prev Policy"],"DOI":"10.1186\/s13011-026-00732-7","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T02:56:31Z","timestamp":1778468191000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inpatient utilization among Medicaid members with substance use disorder in Oregon"],"prefix":"10.1186","volume":"21","author":[{"given":"Daniel J.","family":"Fish","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Holtorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen A.","family":"Lacijan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Gronowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Bouldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Mendenhall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Cohen-Cline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Doren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine J.","family":"Livingston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"732_CR1","unstructured":"Substance Abuse and Mental Health Services Administration. Key substance use and mental Health Indicators in the United States: results from the 2024 National Survey on Drug use and Health. (HHS Publ No PEP25-07-007, NSDUH Ser H-60). Cent Behavioral Health Stat Qual, Subst Abuse Ment Health Serv Adm. July 2025. https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt56287\/2024-nsduh-annual-national-report.pdf."},{"key":"732_CR2","doi-asserted-by":"publisher","DOI":"10.15620\/cdc\/20250305008","volume-title":"Provisional Drug Overdose death counts","author":"F Ahmad","year":"2024","unstructured":"Ahmad F, Cisewski J, Rossen L, Sutton P. Provisional Drug Overdose death counts. 2024. https:\/\/doi.org\/10.15620\/cdc\/20250305008."},{"key":"732_CR3","unstructured":"Substance Abuse and Mental Health Services Administration. 2022\u20132023 National surveys on Drug use and Health: model-based prevalence estimates (50 States and the District of Columbia). https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt56185\/2023-nsduh-sae-tables-percents\/2023-nsduh-sae-tables-percent.pdf."},{"key":"732_CR4","doi-asserted-by":"publisher","unstructured":"Bahji A, Cheng B, Gray S, Stuart H. Mortality among people with Opioid use disorder: a systematic Review and meta-analysis. J Addict Med. 2020;14(4):e118\u201332. https:\/\/doi.org\/10.1097\/ADM.0000000000000606.","DOI":"10.1097\/ADM.0000000000000606"},{"issue":"3","key":"732_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.52965\/001c.38161","volume":"10","author":"A N. Edinof","year":"2022","unstructured":"N. Edinof A, E. Kaufman S, M. Green K, A. Provenzano D, Lawson J, M. Cornett E, et al. Methamphetamine use: a narrative Review of adverse effects and related toxicities. HPR. 2022;10(3):1. https:\/\/doi.org\/10.52965\/001c.38161.","journal-title":"HPR"},{"issue":"3","key":"732_CR6","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/ADM.0000000000000896","volume":"16","author":"AR Lindsay","year":"2022","unstructured":"Lindsay AR, Shearer RD, Bart G, Winkelman TNA. Trends in substance use disorder-related admissions at a safety-net hospital, 2008 \u2013 2020. J Addict Med. 2022;16(3):360\u201363. https:\/\/doi.org\/10.1097\/ADM.0000000000000896.","journal-title":"J Addict Med"},{"key":"732_CR7","unstructured":"Saunders H. A look at substance use disorders (SUD) among Medicaid enrollees. Kaiser Fam Foundation. Report To Congr Medicaid Chip. Preprint posted online 2018. https:\/\/www.kff.org\/mental-health\/issue-brief\/a-look-at-substance-use-disorders-sud-among-medicaid-enrollees\/Medicaid and CHIP Payment and Access Commission (MACPAC)."},{"key":"732_CR8","unstructured":"Medicaid and CHIP Payment and Access Commission (MACPAC). Chapter 4, Behavioral health in the Medicaid program-people, use, and expenditures. 2015. https:\/\/www.macpac.gov\/wp-content\/uploads\/2015\/06\/Behavioral-Health-in-the-Medicaid-Program%E2%80%94People-Use-and-Expenditures.pdf."},{"key":"732_CR9","unstructured":"Saunders H, Euhus R, Burns A, Rudowitz R. SUD treatment in Medicaid: variation by service type, demographics, States and spending. Kaiser Family foundation. 2024 March 28. https:\/\/www.kff.org\/mental-health\/sud-treatment-in-medicaid-variation-by-service-type-demographics-states-and-spending\/."},{"issue":"1","key":"732_CR10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/ADM.0b013e318231de51","volume":"6","author":"AY Walley","year":"2012","unstructured":"Walley AY, Paasche-Orlow M, Lee EC, Forsythe S, Chetty VK, Mitchell S, et al. Acute care hospital utilization among medical Inpatients discharged with a substance use disorder diagnosis. J Addict Med. 2012;6(1):50\u201356. https:\/\/doi.org\/10.1097\/ADM.0b013e318231de51.","journal-title":"J Addict Med"},{"issue":"1","key":"732_CR11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/MLR.0b013e3181bd49ad","volume":"48","author":"DW Ballard","year":"2010","unstructured":"Ballard DW, Price M, Fung V, Brand R, Reed ME, Fireman B, et al. Validation of an Algorithm for categorizing the severity of hospital emergency department visits. Med Care. 2010;48(1):58\u201363. https:\/\/doi.org\/10.1097\/MLR.0b013e3181bd49ad.","journal-title":"Med Care"},{"key":"732_CR12","unstructured":"Agency for Healthcare Research and Quality. AHRQ Quality Indicators-Guide to prevention Quality Indicators: hospital admission for ambulatory care sensitive conditions."},{"key":"732_CR13","unstructured":"Agency for Healthcare Research and Quality. User Guide: Clinical Classifications Software Refined for ICD-10-CM Diagnoses, v2024.1. Preprint posted online 2023."},{"issue":"9","key":"732_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v111.i09","volume":"111","author":"V Arel-Bundock","year":"2024","unstructured":"Arel-Bundock V, Greifer N, Heiss A. How to interpret Statistical models using marginaleffects for R and Python. J Stat Soft. 2024;111(9):1\u201332. https:\/\/doi.org\/10.18637\/jss.v111.i09.","journal-title":"J Stat Soft"},{"key":"732_CR15","doi-asserted-by":"publisher","unstructured":"Rostam-Abadi Y, Wang S, King C, Kalyanaraman Marcello R, Van Wye G, Tuazon E, et al. Addiction consult Services, mortality, and acute care utilization in Inpatients with Opioid use disorder. JAMA Netw Open. 2025;8(8):e2525222. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.25222.","DOI":"10.1001\/jamanetworkopen.2025.25222"},{"issue":"3","key":"732_CR16","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1111\/j.1475-6773.2010.01218.x","volume":"46","author":"MT French","year":"2011","unstructured":"French MT, Fang H, Balsa AI. Longitudinal analysis of changes in illicit Drug use and Health Services utilization. Health Serv Res. 2011;46(3):877\u201399. https:\/\/doi.org\/10.1111\/j.1475-6773.2010.01218.x.","journal-title":"Health Serv Res"},{"issue":"6","key":"732_CR17","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1111\/add.14892","volume":"115","author":"D Lewer","year":"2020","unstructured":"Lewer D, Freer J, King E, Larney S, Degenhardt L, Tweed EJ, et al. Frequency of health-care utilization by adults who use illicit drugs: a systematic review and meta-analysis. Addiction. 2020;115(6):1011\u201323. https:\/\/doi.org\/10.1111\/add.14892.","journal-title":"Addiction"},{"issue":"1","key":"732_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jsat.2009.05.009","volume":"38","author":"MC Raven","year":"2010","unstructured":"Raven MC, Carrier ER, Lee J, Billings JC, Marr M, Gourevitch MN. Substance use treatment barriers for patients with frequent hospital admissions. J Subst Abuse Treat. 2010;38(1):22\u201330. https:\/\/doi.org\/10.1016\/j.jsat.2009.05.009.","journal-title":"J Subst Abuse Treat"},{"issue":"5","key":"732_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.12788\/jhm.2736","volume":"12","author":"H Englander","year":"2017","unstructured":"Englander H, Weimer M, Solotaroff R, Nicolaidis C, Chan B, Velez C, et al. Planning and designing the Improving Addiction care Team (IMPACT) for hospitalized adults with substance use disorder. J Educ Chang Hosp Med. 2017;12(5):339\u201342. https:\/\/doi.org\/10.12788\/jhm.2736.","journal-title":"J Educ Chang Hosp Med"},{"issue":"14","key":"732_CR20","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1001\/jama.2024.27976","volume":"333","author":"AM Dekker","year":"2025","unstructured":"Dekker AM, Schriger DL, Herring AA, Samuels EA. Emergency clinician Buprenorphine initiation, subsequent Prescriptions, and continuous Prescriptions. JAMA. 2025;333(14):1232. https:\/\/doi.org\/10.1001\/jama.2024.27976.","journal-title":"JAMA"},{"issue":"3","key":"732_CR21","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1177\/29767342231221054","volume":"45","author":"DP Watson","year":"2024","unstructured":"Watson DP, Tillson M, Taylor L, Xu H, Ouyang F, Beaudoin FL, et al. Results from the POINT pragmatic randomized trial: an emergency department-based Peer support specialist Intervention to increase Opioid use disorder treatment linkage and reduce recurrent Overdose. Subst Use Addict J. 2024;45(3):378\u201389. https:\/\/doi.org\/10.1177\/29767342231221054.","journal-title":"Subst Use Addict J"},{"key":"732_CR22","doi-asserted-by":"publisher","unstructured":"D\u2019Onofrio G, Edelman EJ, Hawk KF, Chawarski MC, Pantalon MV, Owens PH, et al. Implementation facilitation to promote emergency department\u2013initiated Buprenorphine for Opioid use disorder. JAMA Netw Open. 2023;6(4):e235439. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.5439.","DOI":"10.1001\/jamanetworkopen.2023.5439"},{"issue":"3","key":"732_CR23","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.annemergmed.2021.10.005","volume":"79","author":"KP Chua","year":"2022","unstructured":"Chua KP, Dahlem CHY, Nguyen TD, Brummett CM, Conti RM, Bohnert AS, et al. Naloxone and Buprenorphine prescribing following US emergency department visits for suspected Opioid Overdose: August 2019 to April 2021. Ann Emerg Med. 2022;79(3):225\u201336. https:\/\/doi.org\/10.1016\/j.annemergmed.2021.10.005.","journal-title":"Ann Emerg Med"},{"key":"732_CR24","doi-asserted-by":"publisher","unstructured":"Beaudoin FL, Jacka BP, Li Y, Samuels EA, Hallowell BD, Peachey AM, et al. Effect of a Peer-Led behavioral Intervention for emergency department patients at high risk of fatal Opioid Overdose. JAMA Netw Open. 2022;5(8):e2225582. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.25582.","DOI":"10.1001\/jamanetworkopen.2022.25582"},{"issue":"3","key":"732_CR25","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/acem.14409","volume":"29","author":"BP Jacka","year":"2022","unstructured":"Jacka BP, Ziobrowski HN, Lawrence A, Baird J, Wentz AE, Marshall BDL, et al. Implementation and maintenance of an emergency department naloxone distribution and peer recovery specialist program. Academic Emerg Med. 2022;29(3):294\u2013307. https:\/\/doi.org\/10.1111\/acem.14409.","journal-title":"Academic Emerg Med"},{"issue":"1","key":"732_CR26","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12954-025-01241-9","volume":"22","author":"E Turi","year":"2025","unstructured":"Turi E, Aronowitz S V, Bettencourt A, Li A, Lin J, McFadden R, et al. Scaling up low barrier wound care for people who use drugs: a mixed methods study. Harm Reduct J. 2025;22(1):84. https:\/\/doi.org\/10.1186\/s12954-025-01241-9.","journal-title":"Harm Reduct J"},{"issue":"4","key":"732_CR27","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1007\/s44197-023-00157-6","volume":"13","author":"T Goto","year":"2023","unstructured":"Goto T, Wang C, Kwiat C, Nguyen C, Saligan LN. Community-based wound care programs for unhoused individuals. J Epidemiol Glob Health. 2023;13(4):604\u201314. https:\/\/doi.org\/10.1007\/s44197-023-00157-6.","journal-title":"J Epidemiol Glob Health"},{"issue":"10","key":"732_CR28","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1089\/wound.2020.1243","volume":"10","author":"DP Sanchez","year":"2021","unstructured":"Sanchez DP, Tookes H, Pastar I, Lev-Tov H. Wounds and skin and Soft tissue infections in people who inject drugs and the utility of syringe service programs in their management. Adv Wound Care. 2021;10(10):571\u201382. https:\/\/doi.org\/10.1089\/wound.2020.1243.","journal-title":"Adv Wound Care"},{"key":"732_CR29","doi-asserted-by":"publisher","unstructured":"Huyck M, Mayer S, Messmer S, Yingling C. Community wound care program within a syringe exchange program: Chicago 2018-2019. 2020:110(8):1211\u201313. https:\/\/doi.org\/10.2105\/AJPH.2020.305681","DOI":"10.2105\/AJPH.2020.305681"}],"container-title":["Substance Abuse Treatment, Prevention, and Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13011-026-00732-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-026-00732-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-026-00732-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T02:32:14Z","timestamp":1783045934000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13011-026-00732-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["732"],"URL":"https:\/\/doi.org\/10.1186\/s13011-026-00732-7","relation":{},"ISSN":["1747-597X"],"issn-type":[{"value":"1747-597X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"11 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study adhered to ethical guidelines, and a waiver of informed consent was obtained prior to data analysis. Approval was received from the Providence Health and Services Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Graham Bouldin serves on the board of 211-Info, which provides navigation and referral resources for individuals seeking social services in Oregon. Andrew Mendenhall serves on the board of Health Share of Oregon. The remaining authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45"}}